Materias dentro de su búsqueda.
Mostrando 4,421 - 4,440 Resultados de 5,950 Para Buscar 'Hanussen~', tiempo de consulta: 1.78s Limitar resultados
  1. 4421
    “…Hansen's disease is a chronic infecto-contagious disease caused by Mycobacterium leprae. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Case for diagnosis
  2. 4422
    “…A case of rifampin-induced acute tubular necrosis requiring hemodialysis in a patient receiving thrice-weekly rifampin with daily dapsone for retreatment of relapsed Hansen’s disease is reported. The patient had positive rifampin-dependent antiplatelet antibodies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Acute Tubular Necrosis and Thrombocytopenia Associated With Rifampin Use: Case Report and Review
  3. 4423
    por Hansen, Morten
    Publicado 2009
    “…In Collaboration, author Morten Hansen takes aim at what many leaders inherently know: in today's competitive environment, companywide collaboration is an imperative for successful strategy execution, yet the sought-after synergies are rarely, if ever, realized. …”
    Enlace del recurso
    Collaboration: how leaders avoid the traps, build common ground, and reap big results
  4. 4424
    por Ashida, Hiroshi, Kuraguchi, Kana
    Publicado 2011
    “…Angry, or threatening, faces are easier to find than smiling ones (Hansen & Hansen, 1988) but it remains controversial whether this reflects emotional effects on the basis of the whole face or rather perceptual effects on the basis of parts. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Anger Superiority in Single-Face Judgements
  5. 4425
    por Haussener, Sophia, Steinfeld, Aldo
    Publicado 2012
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effective Heat and Mass Transport Properties of Anisotropic Porous Ceria for Solar Thermochemical Fuel Generation
  6. 4426
    “…Eron, MD, Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Janssen: Advisor/Consultant|Janssen: Grant/Research Support|Merck: Advisor/Consultant|ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support Karam Mounzer, MD, Clinical Care Options: Speakers Bureau|Epividian: Advisor/Consultant|Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Gilead Sciences: Speakers Bureau|Janssen: Advisor/Consultant|Janssen: Grant/Research Support|Janssen: Speakers Bureau|Merck: Advisor/Consultant|Merck: Grant/Research Support|Merck: Speakers Bureau|Prime: Speakers Bureau|Simply Speaking: Speakers Bureau|ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support|ViiV Healthcare: Speakers Bureau Jean A. van Wyk, MBChB, MFPM, ViiV Healthcare Ltd: Stocks/Bonds Vani Vannappagari, MBBS, MPH, PhD, GlaxoSmithKline: Stocks/Bonds|ViiV Healthcare: Employee…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1592. Real-World Utilization and Effectiveness of Long-Acting Cabotegravir + Rilpivirine Among People with HIV with Detectable Viral Loads at Initiation: Trio Cohort Study
  7. 4427
    “…BACKGROUND: In a Phase 3 trial, the Janssen COVID-19 vaccine, Ad26.COV2.S, showed robust efficacy against severe–critical COVID-19 in countries where different SARS-CoV-2 variants were circulating. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB7. Ad26.COV2.S-Elicted Neutralizing Activities Against SARS-CoV-2 Variants of Concern in Phase 1/2a and Phase 3 Clinical Trials
  8. 4428
    “…Age-adjusted breakthrough infection rate per month was highest for Janssen (42.6/100,000 population), followed by AstraZeneca (21.7/100,000 population), Pfizer-BioNTech (8.5/100,000 population), and Moderna (1.8/100,000 population).…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
  9. 4429
    “…Weinberg, DNP, MS, Gilead: Employment|Gilead: Stocks/Bonds Richard Haubrich, MD, Gilead: Employment|Gilead: Stocks/Bonds Stefan Scholten, MD, AbbVie: Advisor/Consultant|AbbVie: Honoraria|Cepheid: Grant/Research Support|Cepheid: Honoraria|Gilead: Advisor/Consultant|Gilead: Grant/Research Support|Gilead: Honoraria|Gilead: Congress and travel support|GSK: Grant/Research Support|Janssen: Advisor/Consultant|Janssen: Honoraria|Janssen: Congress support|ViiV: Advisor/Consultant|ViiV: Grant/Research Support|ViiV: Honoraria|ViiV: Congress and travel support…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1611. Real-World Effectiveness and Tolerability of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Treatment-Experienced People With HIV and a History of Antiretroviral Drug Resistance Mutations
  10. 4430
    “…Popat:  AbbVie, BMS, Janssen, Oncopeptides, and Amgen: Honoraria; Takeda: Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES; GlaxoSmithKline: Consultancy, Honoraria, Research Funding; Abbvie, Takeda, Janssen, and Celgene: Consultancy; Janssen and BMS: Other: travel expenses. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors
  11. 4431
    “…Prof, GlaxoSmithKline, Pfizer, Sanofi, Merck, Moderna, Astra Zeneca, Biofabri, Janssen, Novavax: Advisor/Consultant|GlaxoSmithKline, Pfizer, Sanofi, Merck, Moderna, Astra Zeneca, Biofabri, Janssen, Novavax: Grant/Research Support|GlaxoSmithKline, Pfizer, Sanofi, Merck, Moderna, Astra Zeneca, Biofabri, Janssen, Novavax: Honoraria|GlaxoSmithKline, Pfizer, Sanofi, Merck, Moderna, Astra Zeneca, Biofabri, Janssen, Novavax: Clínical trials fees paid to my institution Tino F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    LB745. Respiratory Syncytial Virus (RSV) Prefusion F Protein Candidate Vaccine (RSVPreF3 OA) is Efficacious in Adults ≥ 60 Years of Age (YOA)
  12. 4432
    “…This was a cross-protocol analysis of four randomized, placebo-controlled efficacy trials (Moderna/mRNA1273, AstraZeneca/AZD1222, Janssen/Ad26.COV2.S, and Novavax/NVX-CoV2373) using a harmonized design. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials
  13. 4433
    “…It has been shown that unsupervised outlier detection methods can be adapted to the one-class classification problem (Janssens and Postma, in: Proceedings of the 18th annual Belgian-Dutch on machine learning, pp 56–64, 2009; Janssens et al. in: Proceedings of the 2009 ICMLA international conference on machine learning and applications, IEEE Computer Society, pp 147–153, 2009. 10.1109/ICMLA.2009.16). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    On the evaluation of outlier detection and one-class classification: a comparative study of algorithms, model selection, and ensembles
  14. 4434
    “…B.J.S. consults for Cambridge Cognition, Servier and Lundbeck; she holds a grant from Janssen/J&J. U.M. has received honoraria for consultancy and speaking at conferences and travel expenses from Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, Pharmacia-Upjohn and UCB Pharma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Personality traits in adults with attention-deficit hyperactivity disorder and their unaffected first-degree relatives
  15. 4435
    “…INTRODUCTION: Janssen received reports of needle detachments for Risperdal(®) CONSTA(®) and, in response, redesigned the kit. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risperdal(®) CONSTA(®) Needle Detachment. Incidence Rates Before and After Kit Redesign: A Retrospective Study using Electronic Health Records and Natural Language Processing in the Department of Veterans Affairs
  16. 4436
    “…PURPOSE: In the United States, Pfizer-BioNTech, Moderna, and Janssen’s coronavirus disease 2019 (COVID-19) vaccines have been granted Emergency Use Authorization (EUA) with the Pfizer-BioNTech vaccine presently approved by the US Food and Drug Administration. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reactogenicity to COVID-19 vaccination in the United States of America
  17. 4437
    “…This paper describes the Janssen experience with the interpretation and application of GVP Module V (Rev 2) regarding the evaluation of safety concerns in an RMP. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)—a company experience
  18. 4438
    “…DISCLOSURE: DFdF, GKS, EF and IR have received research funding from Janssen and H. Lundbeck A/S. RDH and HS have received research funding from Roche, Pfizer, Janssen and Lundbeck. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correlates of late-onset antipsychotic treatment resistance
  19. 4439
    “…Corradini:  KiowaKirin; Incyte; Daiichi Sankyo; Janssen; F. Hoffman-La Roche; Kite; Servier: Consultancy; AbbVie, ADC Theraputics, Amgen, Celgene, Daiichi Sankyo, Gilead/Kite, GSK, Incyte, Janssen, KyowaKirin, Nerviano Medical Science, Novartis, Roche, Sanofi, Takeda: Honoraria; AbbVie, ADC Theraputics, Amgen, Celgene, Daiichi Sankyo, Gilead/Kite, GSK, Incyte, Janssen, KyowaKirin, Nerviano Medical Science, Novartis, Roche, Sanofi, Takeda: Consultancy; Amgen; Takeda; AbbVie: Consultancy, Honoraria, Other: Travel and accommodations; Novartis; Gilead; Celgene: Consultancy, Other: Travel and accommodations; BMS: Other: Travel and accommodation; Sanofi: Consultancy, Honoraria; Incyte: Consultancy; Novartis, Janssen, Celgene, BMS, Takeda, Gilead/Kite, Amgen, AbbVie: Other: travel and accomodations. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey)
  20. 4440
    “…In Canada, Hansen disease (leprosy) is rare and not considered in diagnoses for nonimmigrant patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014
Herramientas de búsqueda: RSS